Author's Response to Letter to the Editor - Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613–627. (2nd December 2022) - Young-Xu, Yinong; Melsheimer, Richard; Emond, Bruno; Lefebvre, Patrick; DerSarkissian, Maral; Lax, Angela; Nguyen, Catherine; Bhak, Rachel H.; Wu, Melody; Lin, Iris